EP0808361A4 - Nouveau procede de replication - Google Patents

Nouveau procede de replication

Info

Publication number
EP0808361A4
EP0808361A4 EP95939952A EP95939952A EP0808361A4 EP 0808361 A4 EP0808361 A4 EP 0808361A4 EP 95939952 A EP95939952 A EP 95939952A EP 95939952 A EP95939952 A EP 95939952A EP 0808361 A4 EP0808361 A4 EP 0808361A4
Authority
EP
European Patent Office
Prior art keywords
replication process
novel replication
novel
replication
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP95939952A
Other languages
German (de)
English (en)
Other versions
EP0808361A1 (fr
Inventor
Robert G Webster
Nicolai V Kaverin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
St Jude Childrens Research Hospital
Original Assignee
St Jude Childrens Research Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by St Jude Childrens Research Hospital filed Critical St Jude Childrens Research Hospital
Priority claimed from CA002205677A external-priority patent/CA2205677A1/fr
Publication of EP0808361A1 publication Critical patent/EP0808361A1/fr
Publication of EP0808361A4 publication Critical patent/EP0808361A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16151—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Catalysts (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Seasonings (AREA)
EP95939952A 1994-11-16 1995-11-13 Nouveau procede de replication Withdrawn EP0808361A4 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US34025494A 1994-11-16 1994-11-16
US340254 1994-11-16
PCT/US1995/014814 WO1996015232A1 (fr) 1994-11-16 1995-11-13 Nouveau procede de replication
CA002205677A CA2205677A1 (fr) 1994-11-16 1997-05-16 Nouveau procede de replication

Publications (2)

Publication Number Publication Date
EP0808361A1 EP0808361A1 (fr) 1997-11-26
EP0808361A4 true EP0808361A4 (fr) 2001-07-18

Family

ID=25679347

Family Applications (1)

Application Number Title Priority Date Filing Date
EP95939952A Withdrawn EP0808361A4 (fr) 1994-11-16 1995-11-13 Nouveau procede de replication

Country Status (6)

Country Link
EP (1) EP0808361A4 (fr)
JP (1) JPH11509081A (fr)
AU (1) AU694592B2 (fr)
NO (1) NO972239L (fr)
NZ (1) NZ296861A (fr)
WO (1) WO1996015232A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5824536A (en) * 1994-08-23 1998-10-20 St. Jude Children's Research Hospital Influenza virus replicated in mammalian cell culture and vaccine production
DE19655440B4 (de) * 1996-04-01 2013-09-05 Novartis Vaccines And Diagnostics Gmbh Verfahren zur Herstellung eines Influenzaimpfstoffs
DE19612966B4 (de) 1996-04-01 2009-12-10 Novartis Vaccines And Diagnostics Gmbh & Co. Kg MDCK-Zellen und Verfahren zur Vermehrung von Influenzaviren
PT1317559E (pt) 2000-04-28 2009-02-12 St Jude Childrens Res Hospital Sistema de transfecção de adn para a produção de vírus infecciosos de arn de cadeia negativa
DE10144906B4 (de) 2001-09-12 2013-11-28 Novartis Vaccines And Diagnostics Gmbh Verfahren zur großtechnischen Herstellung von Impfstoffen
US7790434B2 (en) 2005-06-21 2010-09-07 Medimmune, Llc Methods and compositions for expressing negative-sense viral RNA in canine cells
BRPI0612268A2 (pt) 2005-06-21 2009-01-27 Medimmune Vaccines Inc Ácido nucleico isolado, vetor de expressço, mÉtodos para produzir um rna genâmico da influenza, para produzir um vÍrus da influenza recombinante, para gerar um vÍrus de rna segmentado de filamento negativo recombinante nas cÉlulas caninas cultivadas e para gerar partÍculas virais da influenza infecciosa em cÉlulas caninas cultivadas, cÉlula, e, vÍrus
US7682619B2 (en) 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus
US7883844B2 (en) 2006-05-11 2011-02-08 Juridical Foundation The Chemosero-Therapeutic Research Institute Method for propagating influenza virus
TW201202425A (en) 2010-04-28 2012-01-16 Abbott Biologicals Bv Production of viral components
CN102586195B (zh) * 2011-12-01 2013-09-04 哈药集团生物疫苗有限公司 一种利用Vero传代细胞制备禽流感病毒及其灭活疫苗的方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0019218A2 (fr) * 1979-05-15 1980-11-26 Mobay Corporation Vaccins antigrippaux, procédé pour leur préparation et procédé de propagation des virus de la grippe

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4500513A (en) * 1979-05-15 1985-02-19 Miles Laboratories, Inc. Influenza vaccine production in liquid cell culture

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0019218A2 (fr) * 1979-05-15 1980-11-26 Mobay Corporation Vaccins antigrippaux, procédé pour leur préparation et procédé de propagation des virus de la grippe

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
GOVORKOVA E A ET AL: "REPLICATION OF INFLUENZA A VIRUSES IN A GREEN MONKEY KIDNEY CONTINUOUS CELL LINE (VERO)", JOURNAL OF INFECTIOUS DISEASES,CHICAGO, IL,US, vol. 172, no. 1, July 1995 (1995-07-01), pages 250 - 253, XP000983746, ISSN: 0022-1899 *
KAVERIN N V ET AL: "IMPAIRMENT OF MULTICYCLE INFLUENZA VIRUS GROWTH IN VERO (WHO) CELLSBY LOSS OF TRYPSIN ACTIVITY", JOURNAL OF VIROLOGY,THE AMERICAN SOCIETY FOR MICROBIOLOGY,US, vol. 69, no. 4, April 1995 (1995-04-01), pages 2700 - 2703, XP000983327, ISSN: 0022-538X *
MANCINI D A P ET AL: "AVALIACAO DA TRIPSINA NA MULTIPLICACAO DE VIRUS INFLUENZA EM CULTURAS DE CELULAS MDCK", REVISTA DE FARMACIA E BIOQUIMICA DA UNIVERSIDADE DE SAO PAULO, 1 July 1993 (1993-07-01), XP002039318 *
NISHIMURA H ET AL: "A HUMAN MELANOMA CELL LINE HIGHLY SUSCEPTIBLE TO INFLUENZA C VIRUS", JOURNAL OF GENERAL VIROLOGY,READING, BERKS,GB, vol. 70, 1989, pages 1653 - 1661, XP000983698, ISSN: 0022-1317 *
See also references of WO9615232A1 *
YAMAOKA M ET AL: "MDCK CELL CULTURES SUPPLEMENTED WITH HIGH CONCENTRATIONS OF TRYPSIN EXHIBIT REMARKABLE SUSCEPTIBILITY TO INFLUENZA C VIRUS", ARCHIVES OF VIROLOGY,US,NEW YORK, NY, vol. 140, no. 5, 1995, pages 937 - 944, XP000574756, ISSN: 0304-8608 *

Also Published As

Publication number Publication date
EP0808361A1 (fr) 1997-11-26
NZ296861A (en) 1998-05-27
AU694592B2 (en) 1998-07-23
WO1996015232A1 (fr) 1996-05-23
NO972239D0 (no) 1997-05-15
NO972239L (no) 1997-07-16
JPH11509081A (ja) 1999-08-17
AU4158996A (en) 1996-06-06

Similar Documents

Publication Publication Date Title
GB9400972D0 (en) Process
GB9401969D0 (en) Process
EP0808361A4 (fr) Nouveau procede de replication
GB9419963D0 (en) Process
GB9402604D0 (en) Microbiologial process
GB9403133D0 (en) Process
GB9404020D0 (en) Process
GB9424847D0 (en) Novel process
GB9413408D0 (en) Process
GB9415559D0 (en) Process
GB9405592D0 (en) Process
GB9402607D0 (en) Process
ZA951131B (en) Novel process
GB9401136D0 (en) Novel process
GB9414900D0 (en) Novel process
GB9417971D0 (en) Novel process
GB9416824D0 (en) Novel process
GB9418693D0 (en) Novel process
GB9416408D0 (en) Novel process
GB9418082D0 (en) Novel process
GB9416964D0 (en) Novel process
GB9404056D0 (en) Novel process
GB9404057D0 (en) Novel process
GB9404058D0 (en) Novel process
GB9409604D0 (en) Novel process

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19970111

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20010531

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

RIC1 Information provided on ipc code assigned before grant

Free format text: 7C 12N 7/01 A, 7C 12N 7/02 B, 7C 12N 9/76 B, 7C 12N 7/00 B, 7A 61K 39/145 B, 7C 07K 14/11 B

17Q First examination report despatched

Effective date: 20030623

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

R18D Application deemed to be withdrawn (corrected)

Effective date: 20031104